Serum pepsinogen II: A neglected but useful biomarker to differentiate between diseased and normal stomachs

Clinical meaning of pepsinogen test and Helicobacter pylori serology in the health check-up population in Korea

(2009) Hyun Young Kim et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Serum olfactomedin 4 (GW112, hGC-1) in combination with Reg IV is a highly sensitive biomarker for gastric cancer patients

(2009) Naohide Oue et al.   INTERNATIONAL JOURNAL OF CANCER

Detection of gastric carcinoma-associated MG7-Ag by serum immuno-PCR assay in a high-risk Chinese population, with implication for screening

(2009) Lian Zhang et al.   INTERNATIONAL JOURNAL OF CANCER

Impact of pepsinogen C polymorphism on individual susceptibility to gastric cancer and its precancerous conditions in a Northeast Chinese population

(2009) Li-Ping Sun et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Serum biomarker tests are useful in delineating between patients with gastric atrophy and normal, healthy stomach

(2009) Katsunori Iijima et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile

(2008) Oi Lian Kon et al.   BMC Medical Genomics

GastroPanel: Evaluation of the usefulness in the diagnosis of gastro-duodenal mucosal alterations in children

(2008) Graziella Guariso et al.   CLINICA CHIMICA ACTA

Serum Pepsinogen I, Pepsinogen II, and Gastrin 17 in Relatives of Gastric Cancer Patients: Comparative Study With Type and Severity of Gastritis

(2008) Arghavan Haj–sheykholeslami et al.   Clinical Gastroenterology and Hepatology

Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay

(2008) Li Ping SUN et al.   Journal of Digestive Diseases